Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Michaela Pluskalová"'
Autor:
Michaela Pluskalová, K. Pavlásková, Dana Grebeňová, Kateřina Kuželová, Zbyněk Hrkal, Petr Halada
Publikováno v:
Journal of Cellular Biochemistry. 111:1413-1425
The fusion protein Bcr–Abl, which is the molecular cause of chronic myelogenous leukemia (CML) interacts in multiple points with signaling pathways regulating the cellular adhesivity and cytoskeleton architecture and dynamics. We explored the effec
Autor:
Kateřina Kuželová, Zbyněk Hrkal, Barbora Brodská, Michaela Pluskalová, Dana Grebeňová, Klára Elknerová, Petra Otevřelová
Publikováno v:
Journal of Cellular Biochemistry. 109:184-195
Suberoylanilide hydroxamic acid (SAHA) is an inhibitor of histone deacetylases (HDACs) which is being introduced into clinic for the treatment of hematological diseases. We studied the effect of this compound on six human hematopoietic cell lines (JU
Autor:
Katerina Kuzelova, Michaela Pluskalová, Daniel Kavan, Petr Halada, Zbynek Hrkal, Dana Grebenova
Publikováno v:
Journal of Cellular Biochemistry. 106:673-681
The proteins of 14-3-3 family are substantially involved in the regulation of many biological processes including the apoptosis. We studied the changes in the expression of five 14-3-3 isoforms (β, γ, e, τ, and ζ) during the apoptosis of JURL-MK1
Autor:
Jitka Bartosova, Iuri Marinov, Petr Halada, Zdenka Gasova, Katerina Kuzelova, Michaela Pluskalová
Publikováno v:
Journal of Photochemistry and Photobiology B: Biology. 85:39-48
We investigated the effect of UVA-activated 8-methoxypsoralen (PUVA) on the cell line Karpas 299 derived from anaplastic large-cell lymphoma (ALCL) expressing chimeric fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM/ALK). NPM/ALK activat
Autor:
Iuri Marinov, Michaela Pluskalová, Dana Grebeňová, Zbyněk Hrkal, Kateřina Kuželová, Hana Klamova
Publikováno v:
Scopus-Elsevier
Tyrosine kinase (TK) activity in primary mononuclear blood cells (MNBC) derived from chronic myelogenous leukemia (CML) patients in the chronic phase as well as from healthy donors was measured by a sensitive time-resolved fluorescence method using t
Publikováno v:
Scopus-Elsevier
Publikováno v:
Journal of Photochemistry and Photobiology B: Biology. 73:67-78
5-Aminolaevulinic acid-based photodynamic therapy (ALA-PDT) is used to eliminate cancerous cells through photoactivation of endogenously formed protoporphyrin IX (PPIX) following the administration of PPIX precursor, 5-aminolaevulinic acid (ALA). We
Autor:
J. Suttnar, P. Otevřelová, Dana Grebeňová, B. Brodská, P. Röselová, Daniel Rösel, Kateřina Kuželová, Michaela Pluskalová, Petr Halada
Publikováno v:
Journal of proteomics. 77
We have previously shown that suberoylanilide hydroxamic acid (SAHA) treatment increases the adhesivity of leukemic cells to fibronectin at clinically relevant concentrations. Now, we present the results of the proteomic analysis of SAHA effects on l
Autor:
Katerina, Kuzelová, Michaela, Pluskalová, Barbora, Brodská, Petra, Otevrelová, Klára, Elknerová, Dana, Grebenová, Zbynek, Hrkal
Publikováno v:
Journal of cellular biochemistry. 109(1)
Suberoylanilide hydroxamic acid (SAHA) is an inhibitor of histone deacetylases (HDACs) which is being introduced into clinic for the treatment of hematological diseases. We studied the effect of this compound on six human hematopoietic cell lines (JU
Autor:
Dana Grebenova, Katerina Kuzelova, Michaela Pluskalová, Petr Halada, Gabriela Peslova, Zbynek Hrkal
Publikováno v:
Blood cells, moleculesdiseases. 37(3)
Employing methods of cell biology and proteome analysis tools, we examined effects of an inhibitor of histone deacetylases, sodium butyrate (SB), on the proliferation/differentiation characteristics of chronic myelogenous leukemia (CML)-derived cells